279 studies found for:    CENTRAL SEROUS
Show Display Options
Rank Status Study
1 Unknown  Methotrexate for Central Serous Chorioretinopathy Treatment Trial
Condition: Central Serous Chorioretinopathy
Interventions: Drug: Methotrexate;   Drug: Delayed treatment
2 Recruiting Eplerenone for Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Drug: Eplerenone 50mg
3 Completed High-dose Antioxidants for Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Drug: antioxidants tablets
4 Not yet recruiting A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Interventions: Drug: Eplerenone;   Drug: Maltodextrin
5 Completed Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate
Condition: Chronic Central Serous Chorioretinopathy
Interventions: Drug: Anecortave Acetate Sterile suspension 15 mg;   Drug: Anecortave Acetate
6 Completed Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy
Condition: Central Serous Chorioretinopathy
Interventions: Drug: Verteporfin PDT, half-dose;   Drug: verteporfin PDT, half-fluence
7 Recruiting The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Procedure: Photodynamic therapy
8 Recruiting Micropulse 577nm Laser vs Traditional Laser Treatment in Central Serous Chorioretinopathy
Condition: Central Serous Choroidopathy
Interventions: Device: 577-MPL;   Device: TLT
9 Recruiting Short-Term Oral Mifepristone for Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Interventions: Drug: Mifepristone;   Drug: Placebo
10 Completed
Has Results
Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention:
11 Recruiting Prospective Randomized Controlled Treatment Trial for Chronic Central Serous Chorioretinopathy
Condition: Chronic Central Serous Chorioretinopathy
Interventions: Procedure: Half-dose photodynamic therapy (PDT);   Procedure: Micropulse laser (ML) treatment
12 Completed Micropulse Diode Laser Treatment for Chronic Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Procedure: Subthreshold diode micropulse laser
13 Completed Intravitreal Ranibizumab Treatment of Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Drug: rhuFab V2 [ranibizumab] ( Lucentis )
14 Completed Central Serous Chorioretinopathy: Etiology, Course and Prognosis
Condition: Central Serous Chorioretinopathy
Intervention:
15 Completed Effect of Helicobacter Pylori Treatment on Idiopathic Central Serous Chorioretinopathy (ICSCR)
Condition: Central Serous Chorioretinopathy
Intervention: Drug: omeprazole, Amoxicillin, metronidazole
16 Active, not recruiting Eplerenone for the Treatment of Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Interventions: Drug: 25mg Eplerenone;   Drug: Placebo
17 Completed Persona of Central Serous Chorioretinopathy
Condition: Personality Type
Intervention:
18 Enrolling by invitation The Effect of Therapy With Bevacizumab in Chronic Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Procedure: intravitreal injection with anterior paracentesis
19 Recruiting Treatment Trial for Acute Central Serous Chorioretinopathy
Condition: Acute Central Serous Chorioretinopathy
Interventions: Device: 577-MPL;   Device: 577-TL
20 Completed Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD
Conditions: Age Related Macular Degeneration;   Choroidal Neovascularization;   Central Serous Chorioretinopathy
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years